The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...